{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:26:58Z","timestamp":1772015218322,"version":"3.50.1"},"reference-count":57,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008591","name":"Fahs-Beck Fund for Research and Experimentation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008591","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,3,21]]},"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The Maine Diversion Alert Program grants healthcare providers access to law enforcement data on drug charges. The objectives of this report were to analyse variations in drug charges by demographics and examine recent trends in arrests, prescriptions of controlled substances and overdoses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Observational.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Arrests, controlled prescription medication distribution and overdoses in Maine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Drug arrestees (n=1272) and decedents (n=2432).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary outcome measures<\/jats:title>\n                    <jats:p>Arrestees were analysed by sex and age. Substances involved in arrests were reported by schedule (I\u2013V or non-controlled prescription) and into opioids, stimulants or other classes. Controlled substances reported to the Drug Enforcement Administration (2007\u20132017) were evaluated. Drug-induced deaths (2007\u20132017) reported to the medical examiner were examined by the substance(s) identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Males were more commonly arrested for stimulants and schedule II substances. More than two-thirds of arrests involved individuals under the age of 40. Individuals age\n                      <jats:underline>&gt;<\/jats:underline>\n                      60 were elevated for oxycodone arrests. Over three-fifths (63.38%) of arrests involved schedule II\u2013IV substances. Opioids accounted for almost half (44.6%) of arrests followed by stimulants (32.5%) and sedatives (9.1%). Arrests involving buprenorphine exceeded those for oxycodone, hydrocodone, methadone, tramadol and morphine, combined. Prescriptions for hydrocodone (\u221256.0%) and oxycodone (\u221246.9%) declined while buprenorphine increased (+58.1%) between 2012 and 2017. Deaths from 2007 to 2017 tripled. Acetylfentanyl and furanylfentanyl were the most common fentanyl analogues identified.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although the overall profile of those arrested for drug crimes in 2017 involve males, age &lt;40 and heroin, exceptions (oxycodone for older adults) were observed. Most prescription opioids are decreasing while deaths involving opioids continue to increase in Maine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-027117","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T13:48:27Z","timestamp":1556545707000},"page":"e027117","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine"],"prefix":"10.1136","volume":"9","author":[{"given":"Kevin J","family":"Simpson","sequence":"first","affiliation":[{"name":"Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T","family":"Moran","sequence":"additional","affiliation":[{"name":"Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L","family":"Foster","sequence":"additional","affiliation":[{"name":"Diversion Alert, Houlton, Maine, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipam T","family":"Shah","sequence":"additional","affiliation":[{"name":"Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Y","family":"Chung","sequence":"additional","affiliation":[{"name":"Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie D","family":"Nichols","sequence":"additional","affiliation":[{"name":"Pharmacy Practice, Husson University, Bangor, Maine, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth L","family":"McCall","sequence":"additional","affiliation":[{"name":"Pharmacy Practice, University of New England College of Pharmacy, Portland, Maine, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J","family":"Piper","sequence":"additional","affiliation":[{"name":"Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"2025121514325099000_9.4.e027117.1","unstructured":"Ahmad FB , Rossen LM , Spencer MR , et al . Provisional drug overdose death counts. National Center for Health Statistics 2018 https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"2025121514325099000_9.4.e027117.2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/phar.1952","article-title":"A new tool to tackle the opioid epidemic: description, utility, and results from the Maine Diversion Alert Program","volume":"37","author":"Piper","year":"2017","journal-title":"Pharmacotherapy"},{"key":"2025121514325099000_9.4.e027117.3","doi-asserted-by":"crossref","first-page":"E159","DOI":"10.5888\/pcd13.160229","article-title":"Diversion Alert: 1-year evaluation across northern New England, 2013-2014","volume":"13","author":"Martin","year":"2016","journal-title":"Prev Chronic Dis"},{"key":"2025121514325099000_9.4.e027117.4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.15288\/jsad.2016.77.556","article-title":"Use and misuse of opioids in Maine: Results From pharmacists, the Prescription Monitoring, and the Diversion Alert Programs","volume":"77","author":"Piper","year":"2016","journal-title":"J Stud Alcohol Drugs"},{"key":"2025121514325099000_9.4.e027117.5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amepre.2018.01.034","article-title":"Trends in medical use of opioids in the U.S., 2006-2016","volume":"54","author":"Piper","year":"2018","journal-title":"Am J Prev Med"},{"key":"2025121514325099000_9.4.e027117.6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.forsciint.2018.01.025","article-title":"Illicit and prescription drug misuse as reported to the Maine Diversion Alert Program","volume":"285","author":"Piper","year":"2018","journal-title":"Forensic Sci Int"},{"key":"2025121514325099000_9.4.e027117.7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1159\/000339095","article-title":"Age-related aspects of addiction","volume":"58","author":"Koechl","year":"2012","journal-title":"Gerontology"},{"key":"2025121514325099000_9.4.e027117.8","unstructured":"Centers for Disease Control and Prevention. CDC Vital Signs: prescription painkiller overdoses: a growing epidemic, especially among women. 2013 www.cdc.gov\/vitalsigns\/prescriptionpainkilleroverdoses\/index.html"},{"key":"2025121514325099000_9.4.e027117.9","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014. HHS Publication No. (SMA) 14-4863. NSDUH Series H-48."},{"key":"2025121514325099000_9.4.e027117.10","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200320110-00003"},{"key":"2025121514325099000_9.4.e027117.11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s40429-015-0074-7","article-title":"Pseudoaddiction: fact or fiction? an investigation of the medical literature","volume":"2","author":"Greene","year":"2015","journal-title":"Curr Addict Rep"},{"key":"2025121514325099000_9.4.e027117.12","first-page":"22","article-title":"Prescription drug misuse\/abuse in the elderly","volume":"63","author":"Culberson","year":"2008","journal-title":"Geriatrics"},{"key":"2025121514325099000_9.4.e027117.13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/14659891.2012.685794","article-title":"Controlled substance prescribing trends and physician and pharmacy utilization patterns: epidemiological analysis of the Maine Prescription Monitoring Program from 2006 to 2010","volume":"18","author":"McCall","year":"2013","journal-title":"J. Substance Use"},{"key":"2025121514325099000_9.4.e027117.14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.36076\/ppj.2018.4.309","article-title":"Reframing the prevention strategies of the opioid crisis: focusing on prescription opioids, fentanyl, and heroin epidemic","volume":"21","author":"Manchikanti","year":"2018","journal-title":"Pain Physician"},{"key":"2025121514325099000_9.4.e027117.15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jrh.12307","article-title":"Geographic distribution of providers With a DEA waiver to prescribe buprenorphine for the treatment of Opioid Use Disorder: A 5-year update","volume":"35","author":"Andrilla","year":"2019","journal-title":"J Rural Health"},{"key":"2025121514325099000_9.4.e027117.16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.53558\/FUPK2665","article-title":"Patterns of drug-related mortality in Maine, 1997-2002","volume":"12","author":"Sorg","year":"2003","journal-title":"Maine Policy Review"},{"key":"2025121514325099000_9.4.e027117.17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/0033354918774330","article-title":"The effect of incomplete death certificates on estimates of unintentional opioid-related overdose deaths in the United States, 1999-2015","volume":"133","author":"Buchanich","year":"2018","journal-title":"Public Health Rep"},{"key":"2025121514325099000_9.4.e027117.18","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6712a1"},{"key":"2025121514325099000_9.4.e027117.19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13181-015-0477-9","article-title":"Acetyl fentanyl, a novel fentanyl analog, causes 14 overdose deaths in Rhode Island, March-May 2013","volume":"11","author":"Lozier","year":"2015","journal-title":"J Med Toxicol"},{"key":"2025121514325099000_9.4.e027117.20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/FTD.0000000000000465","article-title":"Acute intoxications and fatalities from illicit fentanyl and analogues: An update","volume":"40","author":"Pichini","year":"2018","journal-title":"Ther Drug Monit"},{"key":"2025121514325099000_9.4.e027117.21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1556-4029.13840","article-title":"Acetyl fentanyl: trends and concentrations in metro detroit","volume":"64","author":"Avedschmidt","year":"2019","journal-title":"J Forensic Sci"},{"key":"2025121514325099000_9.4.e027117.22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.15585\/mmwr.mm6727a4","article-title":"Notes from the field: overdose deaths with carfentanil and other fentanyl analogs detected - 10 states, July 2016-June 2017","volume":"67","author":"O\u2019Donnell","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025121514325099000_9.4.e027117.23","unstructured":"Sorg MH . Expanded Maine drug death report for 2017. 2018 https:\/\/mcspolicycenter.umaine.edu\/wp-content\/uploads\/sites\/122\/2018\/04\/Final-Annual-2017-Drug-Death-Report_.pdf"},{"key":"2025121514325099000_9.4.e027117.24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.53558\/KFAK3555","article-title":"Patterns of drug-induced mortality in Maine, 2015 update","volume":"25","author":"Sorg","year":"2016","journal-title":"Maine Policy Review"},{"key":"2025121514325099000_9.4.e027117.25","unstructured":"DEA. National Heroin Threat Assessment Summary. 2016 https:\/\/www.dea.gov\/divisions\/hq\/2016\/hq062716_attach.pdf"},{"key":"2025121514325099000_9.4.e027117.26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.addbeh.2018.04.017","article-title":"Young adults' opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose","volume":"86","author":"Guarino","year":"2018","journal-title":"Addict Behav"},{"key":"2025121514325099000_9.4.e027117.27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpain.2014.08.010","article-title":"The fentanyl story","volume":"15","author":"Stanley","year":"2014","journal-title":"J Pain"},{"key":"2025121514325099000_9.4.e027117.28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.forsciint.2018.05.042","article-title":"Abuse of fentanyl: An emerging problem to face","volume":"289","author":"Kuczy\u0144ska","year":"2018","journal-title":"Forensic Sci Int"},{"key":"2025121514325099000_9.4.e027117.29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0033354917753119","article-title":"The rapid escalation of fentanyl in illicit drug evidence in Allegheny County, Pennsylvania, 2010-2016","volume":"133","author":"Creppage","year":"2018","journal-title":"Public Health Rep"},{"key":"2025121514325099000_9.4.e027117.30","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"3","author":"Mattick","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121514325099000_9.4.e027117.31","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.038141"},{"key":"2025121514325099000_9.4.e027117.32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/SAR.S138439","article-title":"A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies","volume":"9","author":"McPherson","year":"2018","journal-title":"Subst Abuse Rehabil"},{"key":"2025121514325099000_9.4.e027117.33","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000703"},{"key":"2025121514325099000_9.4.e027117.34","unstructured":"Federal Bureau of Investigations. Uniform Crime Report 2012. 2014 https:\/\/www.fbi.gov\/about-us\/cjis\/ucr\/crime-in-the-u.s\/2012\/crime-in-the-u.s.-2012\/tables\/33tabledatadecoverviewpdf"},{"key":"2025121514325099000_9.4.e027117.35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-9-102"},{"key":"2025121514325099000_9.4.e027117.36","unstructured":"National Institute of Mental Health. Anxiety disorders. 2018 www.nimh.nih.gov\/health\/topics\/anxiety-disorders\/index.shtml"},{"key":"2025121514325099000_9.4.e027117.37","unstructured":"National Heart, Lung, and Blood Institute (NHLBI). Problem sleepiness in your patient. Bethesda, MD: National Institutes of Health, 1997. NIH Publication No. 97-4073."},{"key":"2025121514325099000_9.4.e027117.38","doi-asserted-by":"publisher","DOI":"10.1037\/\/1064-1297.2.3.244"},{"key":"2025121514325099000_9.4.e027117.39","doi-asserted-by":"publisher","DOI":"10.1016\/S1550-8579(08)80005-8"},{"key":"2025121514325099000_9.4.e027117.40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/07448481.2014.891593","article-title":"Effects of gender and motivations on perceptions of nonmedical use of prescription stimulants","volume":"62","author":"Lookatch","year":"2014","journal-title":"J Am Coll Health"},{"key":"2025121514325099000_9.4.e027117.41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.forsciint.2016.02.033","article-title":"The cutting of cocaine and heroin: a critical review","volume":"262","author":"Bros\u00e9us","year":"2016","journal-title":"Forensic Sci Int"},{"key":"2025121514325099000_9.4.e027117.42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.forsciint.2015.09.014","article-title":"Qualitative, quantitative and temporal study of cutting agents for cocaine and heroin over 9 years","volume":"257","author":"Bros\u00e9us","year":"2015","journal-title":"Forensic Sci Int"},{"key":"2025121514325099000_9.4.e027117.43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7517-11-17","article-title":"\u2019South Asian cocktail'--the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour","volume":"11","author":"Ojha","year":"2014","journal-title":"Harm Reduct J"},{"key":"2025121514325099000_9.4.e027117.44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2147\/JMDH.S106340","article-title":"Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology","volume":"9","author":"Mallick-Searle","year":"2016","journal-title":"J Multidiscip Healthc"},{"key":"2025121514325099000_9.4.e027117.45","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"key":"2025121514325099000_9.4.e027117.46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ADM.0000000000000249","article-title":"Bupropion \"abuse\" reported to US Poison Centers","volume":"10","author":"Stassinos","year":"2016","journal-title":"J Addict Med"},{"key":"2025121514325099000_9.4.e027117.47","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0700-x"},{"key":"2025121514325099000_9.4.e027117.48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ADM.0000000000000044","article-title":"Intravenous administration and abuse of bupropion: A case report and a review of the literature","volume":"8","author":"Oppek","year":"2014","journal-title":"J Addict Med"},{"key":"2025121514325099000_9.4.e027117.49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/10903127.2017.1371262","article-title":"Basic and advanced ems providers are equally effective in naloxone administration for opioid overdose in northern New England","volume":"22","author":"Gulec","year":"2018","journal-title":"Prehosp Emerg Care"},{"key":"2025121514325099000_9.4.e027117.50","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6709e1"},{"key":"2025121514325099000_9.4.e027117.51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-007-0039-1","article-title":"Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues","volume":"26","author":"Higashikawa","year":"2008","journal-title":"Forensic Toxicol"},{"key":"2025121514325099000_9.4.e027117.52","unstructured":"Pubchem Open Chemistry database. Carfentanil. 2018 https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/carfentanil#section=Pharmacology-and-Biochemistry"},{"key":"2025121514325099000_9.4.e027117.53","unstructured":"Ricker NN . Only Walgreens selling Narcan in Bangor without a prescription. 2018 https:\/\/bangordailynews.com\/2017\/07\/21\/health\/only-walgreens-selling-narcan-in-bangor-without-a-prescription\/"},{"key":"2025121514325099000_9.4.e027117.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.10.001"},{"key":"2025121514325099000_9.4.e027117.55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5055\/jom.2017.0397","article-title":"Trends in Florida\u2019s prescription drug monitoring program registration and utilization: implications for increasing voluntary use","volume":"13","author":"Delcher","year":"2017","journal-title":"J Opioid Manag"},{"key":"2025121514325099000_9.4.e027117.56","unstructured":"Sacco LN , Duff JH , Sarata AK . Prescription drug monitoring programs. Congressional Research Service:R42593."},{"key":"2025121514325099000_9.4.e027117.57","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000625"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-027117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:33:02Z","timestamp":1765837982000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-027117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,29]]},"published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1136\/bmjopen-2018-027117"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-027117","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}